{"name":"BioNova Pharmaceuticals (Shanghai) LTD.","slug":"bionova-pharmaceuticals-shanghai-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"BN101","genericName":"BN101","slug":"bn101","indication":"Type 2 diabetes","status":"phase_2"}]}],"pipeline":[{"name":"BN101","genericName":"BN101","slug":"bn101","phase":"phase_2","mechanism":"BN101 is a small molecule that targets the SGLT2 receptor.","indications":["Type 2 diabetes"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxPQkFvWGxXbDh2aE83YTN0RDB0c2FCeU1wN05vR1oyRTJ3UVdqbUY3TGY5VEJFdUpsT05DRWFnSFZCSDNEbVNKV2tmcHhQRnh6b21kV3J6Q2hIbWQ1ZjR0dlBHNmVnV091UXE3VG1RQ3MtblA0VTVETDBqaUEyajFuRVd6SkVwQmJ1T2YzQVZBWWk2VGhmcGJEZHJua1V0Zw?oc=5","date":"2025-05-23","type":"pipeline","source":"Servier","summary":"Acute leukemias: New precision therapy - Servier","headline":"Acute leukemias: New precision therapy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi8gFBVV95cUxNRUpVMDVzVENFczFUOWFoTURDMTJUSlJId2dGSk5POHd6TDRMN2h2Qkt4NGZuNFFYZTRRTHpfN2sySnVzQVRfRk9MZ3BMdGRHOXpXREhJNTlucWdqc3FfeF9qYl9ZS1V2cDFOYm1RMUdxSEF2WVNhc0tUOGdDTGJIc1Nac1RveW9VZ2F2SFItTU1hczNIOVdXNmxadTRzM2VEeTRhTWVqb3ZCSE5DdjFCcUV3S2RvZHB0Z0xxaklHOGNKS01fbzZWcWIydURPd0JsU3loUkhWcGJrNHItLVk5RmFjbHhKVVZkdFVnM2hiaWpodw?oc=5","date":"2021-08-20","type":"regulatory","source":"enmobile.prnasia.com","summary":"Insilico Medicine Collaborates with BioNova to Develop Small Molecule Drugs for Hematologic Malignancies - enmobile.prnasia.com","headline":"Insilico Medicine Collaborates with BioNova to Develop Small Molecule Drugs for Hematologic Malignancies","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}